Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 12/20 | 1.00 |
| ▸ | HTR2A | P28223 | 8/20 | 0.61 |
| ▸ | HTR2C | P28335 | 8/20 | 0.61 |
| ▸ | HTR2B | P41595 | 7/20 | 0.61 |
| ▸ | HTR6 | P50406 | 5/20 | 0.61 |
| ▸ | HTR1D | P28221 | 4/20 | 0.61 |
| ▸ | HTR1B | P28222 | 4/20 | 0.61 |
| ▸ | HTR1E | P28566 | 3/20 | 0.61 |
| ▸ | HTR7 | P34969 | 3/20 | 0.61 |
| ▸ | HTR5A | P47898 | 3/20 | 0.61 |
| ▸ | DRD1 | P21728 | 1/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.61 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.61 |
| ▸ | DRD3 | P35462 | 1/20 | 0.61 |
| ▸ | MPO | P05164 | 2/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | HTR1F | P30939 | 3/20 | 0.46 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.45 |
| ▸ | HTR3B | O95264 | 2/20 | 0.45 |
| ▸ | HTR3A | P46098 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25748759 | 0.85 | HTR1A (0.74) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL25241728 | 0.84 | HTR1A (0.72) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL25383625 | 0.82 | HTR1A (0.70) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL25379806 | 0.82 | HTR1A (0.70) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL26202981 | 0.81 | HTR1A (0.68) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL25381818 | 0.80 | HTR1A (0.67) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL12559104 | 0.80 | HTR1A (0.67) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL31708139 | 0.79 | HTR1A (0.66) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL24420531 | 0.78 | HTR1A (0.64) | HTR1AHTR2AHTR2CHTR2BHTR6 | |
| SCHEMBL31708192 | 0.77 | HTR1A (0.63) | HTR1AHTR2AHTR6HTR7MPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-20250059217-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF | BRIGHT MINDS BIOSCIENCES INC. (CA) | 2025-02-20 | — | — | US | disclosed |
| US-20240366638-A1 | PSILOCYBIN ANALOGS FOR TREATING PSYCHOLOGICAL DISORDERS | SYNAPTIVE THERAPEUTICS, LLC | 2024-11-07 | — | — | US | disclosed |
| CN-117897376-A | Heterocyclic compounds and process for preparing same | 光明智慧生物科学公司 | 2024-04-16 | — | — | CN | disclosed |
| EP-4347561-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF | Bright Minds Biosciences Inc. (CA) | 2024-04-10 | — | — | EP | disclosed |
| US-20230405026-A1 | A Method of Treating Depression by Immune Modulation | MYND LIFE SCIENCES INC (CA) | 2023-12-21 | — | — | US | disclosed |
| WO-2023115166-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
| WO-2022246554-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF | BRIGHT MINDS BIOSCIENCES INC. (CA) | 2022-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366638-A1 | PSILOCYBIN ANALOGS FOR TREATING PSYCHOLOGICAL DISORDERS | HTR1B, HTR2B, PNMT | HTR1A 8/4885HTR2A 5/4885HTR2C 4/4885 |
| US-20250059217-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF | OPRL1, OPRK1, CNR2 | HTR1A 306/4885HTR2A 413/4885HTR2C 79/4885 |
| US-20230405026-A1 | A Method of Treating Depression by Immune Modulation | ABCF1, ABCF2, ABCB4 | HTR1A 507/4885HTR2A 377/4885HTR2C 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.